Connect with us

Government

RapidAI Receives FDA Clearance for Rapid SDH (Subdural Hematoma) for Trauma Care

What You Should Know: – RapidAI has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric…

Published

on

This article was originally published by HIT Consultant
RapidAI Receives FDA Clearance for Rapid SDH (Subdural Hematoma) for Trauma Care

What You Should Know:

RapidAI has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma.

– The need for the RapidAI solution is urgent, with SDH cases in US patients expected to increase by nearly 80% before 2040.

AI Module for Detection of Hemispheric Subdural Hematomas

Rapid SDH leverages AI to help neurocritical care teams identify suspected hemispheric subdural hemorrhage faster and with a higher degree of accuracy than traditional methods.

Key features of Rapid SDH include:

– The only hemorrhagic and trauma package to feature hemispheric SDH, ICH and Hyperdensity for faster and complete patient assessment.

– Rapid SDH offers industry leading Positive Predictive Value (PPV) of 99% (sensitivity 93%, specificity 99%) for suspected acute and chronic hemispheric subdural hematomas >1mL.

– Faster results by notifying clinicians in 1 minute or less.

– Automatically sends notifications through the Rapid mobile app, PACS, and email, facilitating treatment and transfer decisions of patients with subdural hematomas.

RapidAI’s goal is to continue to expand the capabilities and applications of its deep AI to deliver comprehensive clinical solutions that provide care teams with the crucial insights necessary to evaluate patients, streamline decision making, and expedite care for this common and dangerous disease.

Psychedelics

Here Are the Champions! Our Top Performing Stories in 2023

It has been quite a year – not just for the psychedelic industry, but also for humanity as a whole. Volatile might not be the most elegant word for it,…

Continue Reading
Medtech

AI can already diagnose depression better than a doctor and tell you which treatment is best

Artificial intelligence (AI) shows great promise in revolutionizing the diagnosis and treatment of depression, offering more accurate diagnoses and predicting…

Continue Reading
Government

Scientists use organoid model to identify potential new pancreatic cancer treatment

A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer…

Continue Reading

Trending

 

NXTLifeScience is part of NXT Financial Media Group. Copyright 2021 NXT.financial media